Asian licensing deals for Ergomed and Aeterna Zentaris’ endometrial cancer drug
6 September 2016 | By Niamh Louise Marriott, Digital Content Producer
Aeterna Zentaris signed an exclusive license agreement with affiliates of Orient EuroPharma for its lead anti-cancer compound, zoptrex, for the initial...